Low dose erythropoietin stimulates bone healing in mice

Journal of Orthopaedic Research

Volumn 29, Issue 2, 2011, Pages 165-172

  Garcia, P ^a,b   Speidel, V ^a,b   Scheuer, C ^a,b   Laschke, M W ^a,b   Holstein, J H ^a,b   Histing, T ^a,b   Pohlemann, T ^a,b   Menger, M D ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b AO FOUNDATION   (Switzerland)

Author keywords

bone healing; bone regeneration; erythropoietin; fracture healing; mouse

Indexed keywords

CD31 ANTIGEN; CYCLINE; ERYTHROPOIETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; DRUG EFFECT; FEMUR; FRACTURE HEALING; HISTOPATHOLOGY; LOW DRUG DOSE; MOUSE; NONHUMAN; OSTEOTOMY; PERIOSTEUM; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANIMALS; BIOMECHANICS; BLOTTING, WESTERN; BONE REGENERATION; BONY CALLUS; ERYTHROPOIETIN; FLOW CYTOMETRY; HEMOGLOBINS; IMMUNOHISTOCHEMISTRY; MICE; PATELLAR DISLOCATION;

EID: 78650954120     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21219     Document Type: Article

References (36)

1. Brines M, Cerami A,. 2008. Erythropoietin-mediated tissue protection: Reducing collateral damage from the primary injury response. J Intern Med 264: 405-432.
2. Holstein JH, Menger MD, Scheuer C, et al. 2007. Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci 80: 893-900.
3. Sorg H, Krueger C, Schulz T, et al. 2009. Effects of erythropoietin in skin wound healing are dose related. FASEB J 23: 3049-3058.
4. Holstein JH, Menger MD, Culemann U, et al. 2007. Development of a locking femur nail for mice. J Biomech 40: 215-219.
5. Garcia P, Holstein JH, Histing T, et al. 2008. A new technique for internal fixation of femoral fractures in mice: Impact of stability on fracture healing. J Biomech 41: 1689-1696.
6. Gensch C, Clever YP, Werner C, et al. 2007. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 192: 67-74.
7. Werner N, Priller J, Laufs U, et al. 2002. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22: 1567-1572.
8. Arcasoy MO,. 2008. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141: 14-31.
9. Savino R, Ciliberto G,. 2004. A paradigm shift for erythropoietin: No longer a specialized growth factor, but rather an all-purpose tissue-protective agent. Cell Death Differ 11 (Suppl 1): S2-S4.
10. Moon C, Krawczyk M, Lakatta EG, et al. 2006. Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats. Cardiovasc Drugs Ther 20: 245-251.
11. Ben-Dor I, Hardy B, Fuchs S, et al. 2007. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model. Cardiovasc Drugs Ther 21: 339-346.
12. Siren AL, Fratelli M, Brines M, et al. 2001. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98: 4044-4049.
13. Villa P, Bigini P, Mennini T, et al. 2003. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198: 971-975.
14. Harder Y, Amon M, Schramm R, et al. 2009. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner. Surgery 145: 372-383.
15. Katz O, Gil L, Lifshitz L, et al. 2007. Erythropoietin enhances immune responses in mice. Eur J Immunol 37: 1584-1593.
16. Santhanam AV, d'Uscio LV, Peterson TE, et al. 2008. Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells. Peptides 29: 1451-1455.
17. Cuzzocrea S, Mazzon E, Di Paola R, et al. 2004. Erythropoietin reduces the development of experimental inflammatory bowel disease. J Pharmacol Exp Ther 311: 1272-1280.
18. Zhu L, Jin W, Pan H, et al. 2009. Erythropoietin inhibits the increase of intestinal labile zinc and the expression of inflammatory mediators after traumatic brain injury in rats. J Trauma 66: 730-736.
19. Einhorn TA,. 2005. The science of fracture healing. J Orthop Trauma 19: S4-S6.
20. Reikeras O, Wang JE, Foster SJ, et al. 2007. Staphylococcus aureus peptidoglycan impairs fracture healing: An experimental study in rats. J Orthop Res 25: 262-266.
21. Yamaguchi T, Takada Y, Maruyama K, et al. 2009. Fra-1/AP-1 impairs inflammatory responses and chondrogenesis in fracture healing. J Bone Miner Res 24: 2056-2065.
22. Bunn JR, Canning J, Burke G, et al. 2004. Production of consistent crush lesions in murine quadriceps muscleâA biomechanical, histomorphological and immunohistochemical study. J Orthop Res 22: 1336-1344.
23. Bunn RJ, Burke G, Connelly C, et al. 2005. InflammationâA double edged sword in high-energy fractures? J Bone Joint Surg Br 87-B: c-265-c-266.
24. Ghosh S, Hayden MS,. 2008. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848.
25. Liu X, Shen J, Jin Y, et al. 2006. Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion. Indian J Med Res 124: 343-354.
26. Toth C, Martinez JA, Liu WQ, et al. 2008. Local erythropoietin signaling enhances regeneration in peripheral axons. Neuroscience 154: 767-783.
27. Tanizawa T, Yamaguchi A, Uchiyama Y, et al. 2000. Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation. Bone 26: 43-53.
28. Buemi M, Galeano M, Sturiale A, et al. 2004. Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22: 169-173. (Pubitemid 40228196)
29. Galeano M, Altavilla D, Cucinotta D, et al. 2004. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53: 2509-2517. (Pubitemid 39145612)
30. Heeschen C, Aicher A, Lehmann R, et al. 2003. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346.
31. Laing AJ, Dillon JP, Condon ET, et al. 2007. Mobilization of endothelial precursor cells: Systemic vascular response to musculoskeletal trauma. J Orthop Res 25: 44-50.
32. Lee DY, Cho TJ, Kim JA, et al. 2008. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone 42: 932-941.
33. Matsumoto T, Mifune Y, Kawamoto A, et al. 2008. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 215: 234-242.
34. Matsumoto T, Kawamoto A, Kuroda R, et al. 2006. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169: 1440-1457.
35. Atesok K, Li R, Stewart DJ, et al. Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res 28: 1007-1014.
36. Matsumoto T, Kuroda R, Mifune Y, et al. 2008. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone 43: 434-439.